We therefore tested ERK1/2 pathway inhibitors in combination with the novel MCL1i AZD599133 using high-throughput combination assays (HTCA) in an 8 × 8 concentration matrix and determining Loewe synergy scores in 12 melanoma and CRC cell lines. The gene discussed is MAPK3; the disease is melanoma.